Current Alzheimer Research

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back Subscribe
Translate in Chinese
Research Article

Neuropsychological Aspects of Sporadic Cerebral Amyloid Angiopathy: A Case Series and Narrative Review

Author(s): Luca Pizzoni*orcid of author, Andrea Cavalliorcid of author, Federica Di Matteo and Giovanni Manciniauthors OrcID

Volume 22, Issue 8, 2025

Published on: 18 August, 2025

Page: [613 - 629] Pages: 17

DOI: 10.2174/0115672050390451250808002719

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: Cerebral Amyloid Angiopathy (CAA) is a common form of cerebral small vessel disease (CSVD), characterized by the accumulation of amyloid-β (Aβ) protein in the walls of cortical and leptomeningeal arteries and arterioles. The sporadic form primarily affects the elderly and is closely associated with Alzheimer’s disease (AD). Despite previous studies on cognition, the specific neuropsychological profile of CAA remains unclear. This study aims to describe the cognitive profile of CAA patients and characterize their neuropsychological aspects in the absence of a clinical diagnosis of AD.

Methods: We present a case series of six patients with probable CAA, without clinical evidence of AD, who underwent extensive neuropsychological assessment. Additionally, a narrative review was conducted to synthesize current knowledge of the cognitive and neuropsychological aspects of sporadic CAA.

Results: The narrative review indicates that CAA predominantly affects executive functioning, processing speed, episodic memory, global cognition, and visuospatial functions. In our case series, all patients exhibited impairments in these domains, except for global cognition. Notably, a specific dissociation was observed in the Rey Auditory Verbal Learning Test (RAVLT), with impaired delayed recall but preserved recognition.

Discussion: Sporadic CAA in patients without AD contributes to cognitive impairment, particularly affecting executive functioning, processing speed, visuospatial functions, and episodic memory. In our sample, memory impairment in CAA follows a dysexecutive pattern, characterized by retrieval deficits with preserved storage. This contrasts with the amnestic profile seen in AD and amnestic mild cognitive impairment (aMCI), where both retrieval and storage are compromised.

Conclusion: This distinct memory profile may represent a useful neuropsychological marker for differentiating CAA-related cognitive impairment from that associated with AD and its prodromal forms. This differentiation has potential implications for diagnosis, prognosis, and the development of tailored therapeutic strategies.

Keywords: Cerebral amyloid angiopathy, Alzheimer’s disease, cognitive impairment, amyloid-β protein, neuropsychological assessment, cerebral small vessel disease, cerebrovascular disorders.

« Previous
[1]
Pantoni L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9(7): 689-701.
[http://dx.doi.org/10.1016/S1474-4422(10)70104-6] [PMID: 20610345]
[2]
Cozza M, Amadori L, Boccardi V. Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment. J Neurol Sci 2023; 454(8): 120866.
[http://dx.doi.org/10.1016/j.jns.2023.120866] [PMID: 37931443]
[3]
Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol 2011; 70(6): 871-80.
[http://dx.doi.org/10.1002/ana.22516] [PMID: 22190361]
[4]
Jäkel L, De Kort AM, Klijn CJM, Schreuder FHBM, Verbeek MM. Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis. Alzheimers Dement 2022; 18(1): 10-28.
[http://dx.doi.org/10.1002/alz.12366] [PMID: 34057813]
[5]
Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: A multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 2022; 21(8): 714-25.
[http://dx.doi.org/10.1016/S1474-4422(22)00208-3] [PMID: 35841910]
[6]
Malhotra K, Theodorou A, Katsanos AH, et al. Prevalence of clinical and neuroimaging markers in cerebral amyloid angiopathy: A systematic review and meta-analysis. Stroke 2022; 53(6): 1944-53.
[http://dx.doi.org/10.1161/STROKEAHA.121.035836] [PMID: 35264008]
[7]
Wermer MJH, Greenberg SM. The growing clinical spectrum of cerebral amyloid angiopathy. Curr Opin Neurol 2018; 31(1): 28-35.
[http://dx.doi.org/10.1097/WCO.0000000000000510] [PMID: 29120920]
[8]
Greenberg SM, Vonsattel JPG, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy. Neurology 1993; 43(10): 2073-9.
[http://dx.doi.org/10.1212/WNL.43.10.2073] [PMID: 8413970]
[9]
Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function. Neurology 2002; 58(11): 1629-34.
[http://dx.doi.org/10.1212/WNL.58.11.1629] [PMID: 12058090]
[10]
Haussmann R, Homeyer P, Sauer C, et al. Comorbid cerebral amyloid angiopathy in dementia and prodromal stages—Prevalence and effects on cognition. Int J Geriatr Psychiatry 2023; 38(10): 6015.
[http://dx.doi.org/10.1002/gps.6015] [PMID: 37847104]
[11]
Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 2011; 69(2): 320-7.
[http://dx.doi.org/10.1002/ana.22112] [PMID: 21387377]
[12]
Boyle PA, Yu L, Nag S, et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 2015; 85(22): 1930-6.
[http://dx.doi.org/10.1212/WNL.0000000000002175] [PMID: 26537052]
[13]
Reijmer YD, Fotiadis P, Martinez-Ramirez S, et al. Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. Brain 2015; 138(1): 179-88.
[http://dx.doi.org/10.1093/brain/awu316] [PMID: 25367025]
[14]
Xiong L, Davidsdottir S, Reijmer YD, et al. Cognitive profile and its association with neuroimaging markers of non-demented cerebral amyloid angiopathy patients in a stroke unit. J Alzheimers Dis 2016; 52(1): 171-8.
[http://dx.doi.org/10.3233/JAD-150890] [PMID: 27060947]
[15]
Xiong L, van Veluw SJ, Bounemia N, et al. Cerebral cortical microinfarcts on magnetic resonance imaging and their association with cognition in cerebral amyloid angiopathy. Stroke 2018; 49(10): 2330-6.
[http://dx.doi.org/10.1161/STROKEAHA.118.022280] [PMID: 30355109]
[16]
Case NF, Charlton A, Zwiers A, et al. Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke 2016; 47(8): 2010-6.
[http://dx.doi.org/10.1161/STROKEAHA.116.012999] [PMID: 27338926]
[17]
Durrani R, Wang M, Cox E, et al. Mediators of cognitive impairment in cerebral amyloid angiopathy. Int J Stroke 2023; 18(1): 78-84.
[http://dx.doi.org/10.1177/17474930221099352] [PMID: 35473418]
[18]
Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: A meta‐analysis. J Neuropsychol 2015; 9(1): 109-36.
[http://dx.doi.org/10.1111/jnp.12039] [PMID: 24612847]
[19]
Weintraub S, Wicklund AH, Salmon DP. The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2(4): a006171.
[http://dx.doi.org/10.1101/cshperspect.a006171] [PMID: 22474609]
[20]
Planton M, Saint-Aubert L, Raposo N, et al. High prevalence of cognitive impairment after intracerebral hemorrhage. PLoS One 2017; 12(6): 0178886.
[http://dx.doi.org/10.1371/journal.pone.0178886] [PMID: 28570698]
[21]
Subotic A, McCreary CR, Saad F, et al. Cortical thickness and its association with clinical cognitive and neuroimaging markers in cerebral amyloid angiopathy. J Alzheimers Dis 2021; 81(4): 1663-71.
[http://dx.doi.org/10.3233/JAD-210138] [PMID: 33998545]
[22]
van Dort R, Kaushik K, Rasing I, et al. Cognition in (pre)symptomatic dutch‐type hereditary and sporadic cerebral amyloid angiopathy. Alzheimers Dement 2024; 20(11): 7518-28.
[http://dx.doi.org/10.1002/alz.14171] [PMID: 39387105]
[23]
Jo S, Cheong EN, Kim N, et al. Role of white matter abnormalities in the relationship between microbleed burden and cognitive impairment in cerebral amyloid angiopathy. J Alzheimers Dis 2022; 86(2): 667-78.
[http://dx.doi.org/10.3233/JAD-215094] [PMID: 35124637]
[24]
Valenti R, Charidimou A, Xiong L, et al. Visuospatial functioning in cerebral amyloid angiopathy: A pilot study. J Alzheimers Dis 2017; 56(4): 1223-7.
[http://dx.doi.org/10.3233/JAD-160927] [PMID: 28222510]
[25]
Su Y, Fu J, Zhang Y, Xu J, Dong Q, Cheng X. Visuospatial dysfunction is associated with posterior distribution of white matter damage in non‐demented cerebral amyloid angiopathy. Eur J Neurol 2021; 28(9): 3113-20.
[http://dx.doi.org/10.1111/ene.14993] [PMID: 34157199]
[26]
Schrag M, Kirshner H. Neuropsychological effects of cerebral amyloid angiopathy. Curr Neurol Neurosci Rep 2016; 16(8): 76.
[http://dx.doi.org/10.1007/s11910-016-0674-1] [PMID: 27357378]
[27]
Planton M, Raposo N, Albucher JF, Pariente J. Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern. Rev Neurol 2017; 173(9): 562-5.
[http://dx.doi.org/10.1016/j.neurol.2017.09.006] [PMID: 28993004]
[28]
Schiavolin S, Camarda G, Mazzucchelli A, et al. Cognitive and psychological characteristics in patients with cerebral amyloid angiopathy: A literature review. Neurol Sci 2024; 45(7): 3031-49.
[http://dx.doi.org/10.1007/s10072-024-07399-7] [PMID: 38388894]
[29]
Chan E, Bonifacio GB, Harrison C, et al. Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage. J Neurol 2023; 270(12): 6124-32.
[http://dx.doi.org/10.1007/s00415-023-11977-8] [PMID: 37672105]
[30]
Barucci E, Salvadori E, Magi S, et al. Cognitive profile in cerebral small vessel disease: Comparison between cerebral amyloid angiopathy and hypertension-related microangiopathy. Sci Rep 2024; 14(1): 5922.
[http://dx.doi.org/10.1038/s41598-024-55719-w] [PMID: 38467658]
[31]
Hyman BT, Phelps CH, Beach TG, et al. National institute on aging-alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 2012; 8(1): 1-13.
[http://dx.doi.org/10.1016/j.jalz.2011.10.007] [PMID: 22265587]
[32]
Schoemaker D, Charidimou A, Zotin ZMC, et al. Association of memory impairment with concomitant tau pathology in patients with cerebral amyloid angiopathy. Neurology 2021; 96(15): e1975-86.
[http://dx.doi.org/10.1212/WNL.0000000000011745] [PMID: 33627498]
[33]
Tsai HH, Liu CJ, Lee BC, et al. Cerebral tau pathology in cerebral amyloid angiopathy. Brain Commun 2024; 6(2): fcae086.
[http://dx.doi.org/10.1093/braincomms/fcae086] [PMID: 38638152]
[34]
Rabin JS, Nichols E, La Joie R, et al. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain 2022; 145(8): 2823-33.
[http://dx.doi.org/10.1093/brain/awac178] [PMID: 35759327]
[35]
Godrich D, Pasteris J, Martin ER, et al. Cerebral amyloid angiopathy impacts neurofibrillary tangle burden and cognition. Brain Commun 2024; 6(6): fcae369.
[http://dx.doi.org/10.1093/braincomms/fcae369] [PMID: 39584156]
[36]
Theodorou A, Athanasaki A, Melanis K, et al. Cognitive impairment in cerebral amyloid angiopathy: A single-center prospective cohort study. J Clin Med 2024; 13(23): 7427.
[http://dx.doi.org/10.3390/jcm13237427] [PMID: 39685885]
[37]
De Kort AM, Kaushik K, Kuiperij HB, et al. The relation of a cerebrospinal fluid profile associated with Alzheimer’s disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy. Alzheimers Res Ther 2024; 16(1): 99.
[http://dx.doi.org/10.1186/s13195-024-01454-3] [PMID: 38704569]
[38]
Riley DS, Barber MS, Kienle GS, et al. CARE guidelines for case reports: Explanation and elaboration document. J Clin Epidemiol 2017; 89: 218-35.
[http://dx.doi.org/10.1016/j.jclinepi.2017.04.026] [PMID: 28529185]
[39]
Fabrizi E, Ancidoni A, Locuratolo N, et al. The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment. Age Ageing 2024; 53(11): afae250.
[http://dx.doi.org/10.1093/ageing/afae250] [PMID: 39544104]
[40]
Salvadori E, Brambilla M, Cova I, Pomati S, Pantoni L. Cognitive evaluation in cerebral small vessel disease: towards an evidence-based identification of the reference standards. Part 1. A systematic review and qualitative data synthesis. J Neurol 2021; 268(12): 4563-72.
[http://dx.doi.org/10.1007/s00415-020-10262-2] [PMID: 33048216]
[41]
Salvadori E, Brambilla M, Maestri G, et al. The clinical profile of cerebral small vessel disease: Toward an evidence‐based identification of cognitive markers. Alzheimers Dement 2023; 19(1): 244-60.
[http://dx.doi.org/10.1002/alz.12650] [PMID: 35362229]
[42]
Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M. Mini‐mental state examination: A normative study in Italian elderly population. Eur J Neurol 1996; 3(3): 198-202.
[http://dx.doi.org/10.1111/j.1468-1331.1996.tb00423.x] [PMID: 21284770]
[43]
Carlesimo GA, Caltagirone C, Gainotti G, et al. The mental deterioration battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 1996; 36(6): 378-84.
[http://dx.doi.org/10.1159/000117297] [PMID: 8954307]
[44]
Costa A, Bagoj E, Monaco M, et al. Standardization and normative data obtained in the Italian population for a new verbal fluency instrument, the phonemic/semantic alternate fluency test. Neurol Sci 2014; 35(3): 365-72.
[http://dx.doi.org/10.1007/s10072-013-1520-8] [PMID: 23963806]
[45]
Siciliano M, Chiorri C, Battini V, et al. Regression-based normative data and equivalent scores for trail making test (TMT): An updated Italian normative study. Neurol Sci 2019; 40(3): 469-77.
[http://dx.doi.org/10.1007/s10072-018-3673-y] [PMID: 30535956]
[46]
Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Una versione abbreviata del test di Stroop: Dati normativi nella popolazione italiana. Riv Neurol 2002; 12(4): 111-5.
[47]
Monaco M, Costa A, Caltagirone C, Carlesimo GA. Erratum to: Forward and backward span for verbal and visuo-spatial data: Standardization and normative data from an Italian adult population. Neurol Sci 2015; 36(2): 345-7.
[http://dx.doi.org/10.1007/s10072-014-2019-7] [PMID: 25491661]
[48]
Aiello EN, Esposito A, Gramegna C, et al. The frontal assessment battery (FAB) and its sub-scales: Validation and updated normative data in an Italian population sample. Neurol Sci 2022; 43(2): 979-84.
[http://dx.doi.org/10.1007/s10072-021-05392-y] [PMID: 34184168]
[49]
Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey-Osterrieth complex figure: Normative values in an Italian population sample. Neurol Sci 2002; 22(6): 443-7.
[http://dx.doi.org/10.1007/s100720200003] [PMID: 11976975]
[50]
Ricci M, Ruggeri M, Gnisci C, Pizzoni L, Gerace C, Blundo C. Improving amnesia diagnostic accuracy with RAVLT single scores and composite indices: Italian normative data. Arch Clin Neuropsychol 2022; 37(8): 1749-64.
[http://dx.doi.org/10.1093/arclin/acac055] [PMID: 35870196]
[51]
Rey A. Rey auditory verbal learning test (RAVLT) L’Examen clinique en psychologie. Paris: Presse Universitaires de France 1964.
[52]
Ricci M, Graef S, Blundo C, Miller LA. Using the rey auditory verbal learning test (RAVLT) to differentiate Alzheimer’s dementia and behavioural variant fronto-temporal dementia. Clin Neuropsychol 2012; 26(6): 926-41.
[http://dx.doi.org/10.1080/13854046.2012.704073] [PMID: 22809061]
[53]
Vakil E, Blachstein H. Rey auditory-verbal learning test: Structure analysis. J Clin Psychol 1993; 49(6): 883-90.
[http://dx.doi.org/10.1002/1097-4679(199311)49:6<883:AID-JCLP2270490616>3.0.CO;2-6] [PMID: 8300877]
[54]
Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological Assessment. (5th ed.). New York: Oxford University Press 2012; pp. 419-26.
[55]
Spinnler H, Tognoni G. Italian standardization and calibration of neuropsychological tests. Ital J Neurol Sci 1987; 6: 25-7.
[56]
Bennett IJ, Golob EJ, Parker ES, Starr A. Memory evaluation in mild cognitive impairment using recall and recognition tests. J Clin Exp Neuropsychol 2006; 28(8): 1408-22.
[http://dx.doi.org/10.1080/13803390500409583] [PMID: 17050267]
[57]
Greenaway MC, Lacritz LH, Binegar D, Weiner MF, Lipton A, Munro Cullum C. Patterns of verbal memory performance in mild cognitive impairment, Alzheimer disease, and normal aging. Cogn Behav Neurol 2006; 19(2): 79-84.
[http://dx.doi.org/10.1097/01.wnn.0000208290.57370.a3] [PMID: 16783130]
[58]
Wolk DA, Signoff ED, DeKosky ST. Recollection and familiarity in amnestic mild cognitive impairment: A global decline in recognition memory. Neuropsychologia 2008; 46(7): 1965-78.
[http://dx.doi.org/10.1016/j.neuropsychologia.2008.01.017] [PMID: 18328509]
[59]
Chang YL, Bondi MW, Fennema-Notestine C, et al. Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer’s disease. Neuropsychologia 2010; 48(5): 1237-47.
[http://dx.doi.org/10.1016/j.neuropsychologia.2009.12.024] [PMID: 20034503]
[60]
Balthazar MLF, Yasuda CL, Cendes F, Damasceno BP. Learning, retrieval, and recognition are compromised in aMCI and mild AD: Are distinct episodic memory processes mediated by the same anatomical structures? J Int Neuropsychol Soc 2010; 16(1): 205-9.
[http://dx.doi.org/10.1017/S1355617709990956] [PMID: 19835661]
[61]
Russo MJ, Cohen G, Campos J, et al. Usefulness of discriminability and response bias indices for the evaluation of recognition memory in mild cognitive impairment and alzheimer disease. Dement Geriatr Cogn Disord 2017; 43(1-2): 1-14.
[http://dx.doi.org/10.1159/000452255] [PMID: 27889770]
[62]
Russo MJ, Campos J, Vázquez S, Sevlever G, Allegri RF. Adding recognition discriminability index to the delayed recall is useful to predict conversion from mild cognitive impairment to Alzheimer’s disease in the Alzheimer’s disease neuroimaging initiative. Front Aging Neurosci 2017; 9: 46.
[http://dx.doi.org/10.3389/fnagi.2017.00046] [PMID: 28344552]
[63]
Tomadesso C, de La Sayette V, de Flores R, et al. Neuropsychology and neuroimaging profiles of amyloid‐positive versus amyloid‐negative amnestic mild cognitive impairment patients. Alzheimers Dement 2018; 10(1): 269-77.
[http://dx.doi.org/10.1016/j.dadm.2018.02.008] [PMID: 29780872]
[64]
De Simone MS, Perri R, Fadda L, Caltagirone C, Carlesimo GA. Predicting progression to Alzheimer’s disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests. J Neurol 2019; 266(1): 102-11.
[http://dx.doi.org/10.1007/s00415-018-9108-0] [PMID: 30386876]
[65]
Goldstein FC, Loring DW, Thomas T, Saleh S, Hajjar I. Recognition memory performance as a cognitive marker of prodromal Alzheimer’s disease. J Alzheimers Dis 2019; 72(2): 507-14.
[http://dx.doi.org/10.3233/JAD-190468] [PMID: 31594225]
[66]
De Simone MS, Lombardi MG, De Tollis M, et al. Forgetting rate for the familiarity and recollection components of recognition in amnestic mild cognitive impairment: A longitudinal study. Appl Neuropsychol Adult 2024; 31(6): 1411-23.
[http://dx.doi.org/10.1080/23279095.2022.2135441] [PMID: 36264763]
[67]
Delis DC, Massman PJ, Butters N, Salmon DP, Cermak LS, Kramer JH. Profiles of demented and amnesic patients on the California verbal learning test: Implications for the assessment of memory disorders. Psychol Assess 1991; 3(1): 19-26.
[http://dx.doi.org/10.1037/1040-3590.3.1.19]
[68]
Clark LR, Stricker NH, Libon DJ, et al. Yes/no versus forced-choice recognition memory in mild cognitive impairment and Alzheimer’s disease: Patterns of impairment and associations with dementia severity. Clin Neuropsychol 2012; 26(7): 1201-16.
[http://dx.doi.org/10.1080/13854046.2012.728626] [PMID: 23030301]
[69]
Westerberg C, Mayes A, Florczak SM, et al. Distinct medial temporal contributions to different forms of recognition in amnestic mild cognitive impairment and Alzheimer’s disease. Neuropsychologia 2013; 51(12): 2450-61.
[http://dx.doi.org/10.1016/j.neuropsychologia.2013.06.025] [PMID: 23831717]
[70]
Caruso G, Perri R, Fadda L, Caltagirone C, Carlesimo GA. Recall and recognition in Alzheimer’s disease and frontotemporal dementia. J Alzheimers Dis 2020; 77(2): 655-66.
[http://dx.doi.org/10.3233/JAD-200126] [PMID: 32741812]
[71]
Juhlin F, Mellqvist J, Eckerström M, Hellström P. Rey auditory verbal learning test in idiopathic normal pressure hydrocephalus and Alzheimer’s disease. Clin Neuropsychol 2024; 38(1): 202-18.
[http://dx.doi.org/10.1080/13854046.2023.2200977] [PMID: 37051850]
[72]
Looi JCL, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999; 53(4): 670-8.
[http://dx.doi.org/10.1212/WNL.53.4.670] [PMID: 10489025]
[73]
Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Dis Assoc Disord 2014; 28(3): 206-18.
[http://dx.doi.org/10.1097/WAD.0000000000000034] [PMID: 24632990]
[74]
Seki M, Yoshizawa H, Hosoya M, Kitagawa K. Neuropsychological profile of early cognitive impairment in cerebral small vessel disease. Cerebrovasc Dis 2022; 51(5): 600-7.
[http://dx.doi.org/10.1159/000522438] [PMID: 35378532]
[75]
Gleichgerrcht E, Torralva T, Martinez D, Roca M, Manes F. Impact of executive dysfunction on verbal memory performance in patients with Alzheimer’s disease. J Alzheimers Dis 2011; 23(1): 79-85.
[http://dx.doi.org/10.3233/JAD-2010-100990] [PMID: 20930305]
[76]
Consonni M, Rossi S, Cerami C, et al. Executive dysfunction affects word list recall performance: Evidence from amyotrophic lateral sclerosis and other neurodegenerative diseases. J Neuropsychol 2017; 11(1): 74-90.
[http://dx.doi.org/10.1111/jnp.12072] [PMID: 25952058]
[77]
Melrose RJ, Zahniser E, Wilkins SS, et al. Prefrontal working memory activity predicts episodic memory performance: A neuroimaging study. Behav Brain Res 2020; 379: 112307.
[http://dx.doi.org/10.1016/j.bbr.2019.112307] [PMID: 31678217]
[78]
Libon DJ, Drabick DAG, Giovannetti T, et al. Neuropsychological syndromes associated with Alzheimer’s/vascular dementia: A latent class analysis. J Alzheimers Dis 2014; 42(3): 999-1014.
[http://dx.doi.org/10.3233/JAD-132147] [PMID: 25024329]
[79]
Hu H, Wan S, Hu Y, Wang Q, Li H, Zhang N. Deciphering the role of APOE in cerebral amyloid angiopathy: From genetic insights to therapeutic horizons. Ann Med 2025; 57(1): 2445194.
[http://dx.doi.org/10.1080/07853890.2024.2445194] [PMID: 39745195]
[80]
Doran SJ, Sawyer RP. Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications. Front Neurosci 2024; 18: 1326784.
[http://dx.doi.org/10.3389/fnins.2024.1326784] [PMID: 38312931]

Rights & Permissions Print Cite